BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29170084)

  • 1. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
    Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific autoantibody against a novel tumour-association antigen derived from human DNA-topoiomerase I is a potential biomarker for early diagnosis and favourable prognosis in patients with colorectal carcinoma.
    Zhao F; Cao M; Jiang XH; Xie K; Ye SR; Yie SM
    Biomarkers; 2020 Mar; 25(2):149-156. PubMed ID: 31922440
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
    World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of plasma anti-TOPO48 autoantibody and blood survivin-expressing circulating cancer cells in patients with early stage endometrial carcinoma.
    Jiang XH; Yao ZY; He X; Zhang JB; Xie K; Chen J; Cao M; Zhang J; Yie SM
    Arch Gynecol Obstet; 2019 Jan; 299(1):229-237. PubMed ID: 30341503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
    Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
    World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
    Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
    Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.
    Kobayashi S; Hiwasa T; Ishige T; Rahmutulla B; Kano M; Hoshino T; Minamoto T; Shimada H; Nomura F; Matsubara H; Matsushita K
    Cancer Sci; 2019 Jun; 110(6):2004-2013. PubMed ID: 30980774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Autoantibody Against Human DNA-Topoisomerase I Is a Novel Biomarker for Non-Small Cell Lung Cancer.
    Wu WB; Yie SM; Ye SR; Xie K; Zhang JB; Cao M; Chen J; He X; Ma XL; Zhang J
    Ann Thorac Surg; 2018 Jun; 105(6):1664-1670. PubMed ID: 29453962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
    Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
    Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
    Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Validation of a Serologic Autoantibody Panel for Early Diagnosis of Esophageal Squamous Cell Carcinoma.
    Pan J; Zheng QZ; Li Y; Yu LL; Wu QW; Zheng JY; Pan XJ; Xie BS; Wu YA; Qian J; Zhu H; Huang Y
    Cancer Epidemiol Biomarkers Prev; 2019 Sep; 28(9):1454-1460. PubMed ID: 31239266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
    Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
    Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
    Chen J; Chen M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1048-1053. PubMed ID: 30523223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
    Zhou JH; Zhang B; Kernstine KH; Zhong L
    World J Gastroenterol; 2011 Mar; 17(10):1373-8. PubMed ID: 21455340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
    Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
    BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
    Wang C; Sun G; Wang H; Dai L; Zhang J; Du R
    BMC Cancer; 2022 Aug; 22(1):932. PubMed ID: 36038839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.